Table 2.
Baseline Characteristics of Participants in Study Sample 2 vs Nonattendees
| Clinical Features | Men Attending Examination 2 (n=1202) | Men Not Attending Examination 2 (n=710) | P Value | Women Attending Examination 2 (n=1467) | Women Not Attending Examination 2 (n=716) | P Value |
|---|---|---|---|---|---|---|
| Age, y | 40.2 (8.5) | 40.5 (9.4) | 0.481 | 40.1 (8.7) | 39.9 (9.1) | 0.751 |
| Systolic BP, mm Hg | 120.0 (12.1) | 122.2 (13.3) | 0.001 | 112.8 (14.0) | 114.1 (15.1) | 0.050 |
| Diastolic BP, mm Hg | 78.0 (9.2) | 79.0 (9.4) | 0.025 | 72.3 (9.2) | 73.4 (9.2) | 0.009 |
| Hypertension, % | 19.0 | 27.3 | <0.0001 | 10.0 | 16.3 | <0.0001 |
| Treatment for hypertension, % | 8.0 | 14.1 | <0.0001 | 5.3 | 11.2 | <0.0001 |
| BMI, kg/m² | 27.7 (4.4) | 28.4 (5.2) | 0.002 | 25.5 (5.5) | 27.2 (7.1) | <0.0001 |
| BMI ≥30 kg/m², % | 23.8 | 29.5 | 0.005 | 17.9 | 26.9 | <0.0001 |
| Weight, kg | 87.6 (15.0) | 89.4 (17.4) | 0.017 | 68.7 (15.2) | 72.9 (19.4) | <0.0001 |
| Waist circumference, cm | 97.6 (12.0) | 99.5 (13.7) | 0.002 | 87.1 (14.3) | 91.5 (18.0) | <0.0001 |
| Total cholesterol, mg/dL | 193.7 (36.2) | 191.9 (38.9) | 0.335 | 184.3 (32.2) | 187.0 (34.5) | 0.092 |
| Triglycerides, mg/dL | 128.7 (91.9) | 149.2 (135.5) | 0.001 | 91.8 (50.6) | 109.5 (80.3) | <0.0001 |
| HDL‐C, mg/dL | 46.9 (11.9) | 46.5 (13.4) | 0.508 | 61.9 (15.8) | 59.0 (16.3) | <0.0001 |
| Current smoker, % | 15.6 | 23.4 | <0.0001 | 13.4 | 21.9 | <0.0001 |
| Fasting plasma glucose, mg/dL | 95.9 (7.6) | 103.6 (27.6) | <0.0001 | 89.8 (7.5) | 96.9 (29.3) | <0.0001 |
Values for clinical features are means±SD or percentages. BMI indicates body mass index; BP, blood pressure; HDL‐C, high‐density lipoprotein cholesterol; HOMA‐IR, homeostasis model assessment insulin resistance index.